Core Viewpoint - Tianyu Co., Ltd. (300702.SZ) announced the completion of a share reduction plan by its controlling shareholder, Tu Shanzeng, who reduced his holdings by 3,444,900 shares, representing 0.99% of the total share capital, leading to a decrease in the combined shareholding of the controlling shareholder and its concerted parties from 58.68% to 57.69% [1] Summary by Relevant Sections - **Share Reduction Details** - Tu Shanzeng reduced his holdings by a total of 10,404,443 shares from September 24 to October 15, 2025, accounting for 2.99% of the total share capital [1] - The average prices for the share reductions were as follows: - Block trades: 20.48 CNY/share and 20.64 CNY/share - Centralized bidding: 25.88 CNY/share, 25.03 CNY/share, 24.33 CNY/share, and 23.76 CNY/share [2] - The total cash generated from this reduction was approximately 227 million CNY [2] - **Previous Announcements** - On June 26, 2025, the company disclosed a pre-announcement regarding Tu Shanzeng's plan to reduce his holdings by up to 3,479,771 shares (1.00%) through centralized bidding and up to 6,959,543 shares (2.00%) through block trades within three months [3] - **Shareholding Structure** - The largest shareholder, Lin Jie, and the second-largest shareholder, Tu Yongjun, are a married couple, holding 122,028,474 shares and 57,109,409 shares, respectively [3] - **Financial Activities** - Tianyu Co., Ltd. previously raised approximately 899.99 million CNY through a specific issuance of shares, with a net amount of 894.06 million CNY after deducting related expenses [4][5] - The company had plans to issue convertible bonds to raise up to 1.4 billion CNY for a project and working capital, but the plan expired automatically [6]

Core Viewpoint - Tianyu Co., Ltd. (300702.SZ) announced that shareholder Shu Shanzeng has completed a share reduction plan, reducing his holdings in the company [1] Group 1: Share Reduction Details - From October 10 to October 15, 2025, Shu Shanzeng reduced his holdings by 3,444,900 shares, representing 0.99% of the company's total share capital [1] - The combined shareholding of the company's controlling shareholder and its concerted parties decreased from 58.68% to 57.69% due to this reduction [1] - As of October 15, 2025, Shu Shanzeng has cumulatively reduced his holdings by 10,404,443 shares through both centralized bidding and block trading methods, completing the reduction plan [1]

Core Viewpoint - Tianyu Co., Ltd. (300702.SZ) announced the completion of a share reduction plan by shareholder Shu Shanzeng, who reduced his holdings by 3,444,900 shares, representing 0.99% of the company's total share capital [1] Summary by Relevant Sections - **Share Reduction Details** - Shu Shanzeng reduced his holdings from October 10, 2025, to October 15, 2025, through centralized bidding transactions [1] - The combined shareholding of the controlling shareholder and its concerted parties decreased from 58.68% to 57.69% following this reduction [1] - As of October 15, 2025, Shu Shanzeng has cumulatively reduced his holdings by 10,404,443 shares through both centralized bidding and block trading [1]

证券代码：300702 证券简称：天宇股份 公告编号：2025-071 浙江天宇药业股份有限公司 关于控股股东、实际控制人之一致行动人减持股份触及 1%整数 倍暨减持计划实施完成的公告 股东屠善增保证向本公司提供的信息内容真实、准确、完整， 没有虚假记 载、误导性陈述或重大遗漏。 本公司董事会及全体董事保证本公告内容不存在虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 浙江天宇药业股份有限公司（以下简称"公司"）于2025年6月26日披露了《关 于控股股东、实际控制人之一致行动人减持股份的预披露公告》（公告编号： 2025-040），公司控股股东、实际控制人之一致行动人屠善增先生计划自公告披 露之日起15个交易日后的3个月内，以集中竞价方式减持公司股份不超过 3,479,771股（占本公司总股本比例1.00%），以大宗交易方式减持公司股份不超过 6,959,543股（占本公司总股本比例2.00%）。 1.基本情况 信息披露义务人 屠善增 住所 浙江省台州市黄岩区 权益变动时间 2025 年 10 月 10 日至 2025 年 10 月 15 日 权益变动过程 202 ...

Core Viewpoint - Tianyu Co., Ltd. experienced a significant block trade on October 9, with a transaction volume of 4.5933 million shares and a transaction value of 94.8057 million yuan, indicating a discount of 19.63% compared to the closing price of the day [2] Group 1: Block Trade Details - The block trade price was 20.64 yuan per share, which is lower than the market closing price [2] - The buyer was an institutional special account, while the seller was Zhejiang Securities Co., Ltd. from the Taizhou Huancheng East Road branch [2] - In the last three months, Tianyu Co., Ltd. has recorded a total of three block trades, amounting to a cumulative transaction value of 156 million yuan [2] Group 2: Market Performance - On the same day, Tianyu Co., Ltd. closed at 25.68 yuan, down 0.47%, with a turnover rate of 1.64% and a total transaction value of 89.2133 million yuan [2] - The net outflow of main funds for the day was 911,500 yuan, and over the past five days, the stock has seen a cumulative decline of 1.50% with a total net outflow of 6.2975 million yuan [2]

Group 1 - The core point of the article is that Tianyu Co., Ltd. (300702.SZ) announced a share reduction by shareholder Shu Shanzeng, who sold 4,593,299 shares through block trading, representing 1.32% of the company's total share capital [1] - Following this transaction, the combined shareholding of the company's controlling shareholder and its concerted parties decreased from 60.00% to 58.68% [1] - The change in shareholder equity triggered a change that touches the integer multiple of 1% [1]

浙江天宇药业股份有限公司（以下简称"公司"）于2025年6月26日披露了《关 于控股股东、实际控制人之一致行动人减持股份的预披露公告》（公告编号： 2025-040），公司控股股东、实际控制人之一致行动人屠善增先生计划自公告披 露之日起15个交易日后的3个月内，以集中竞价方式减持公司股份不超过 3,479,771股（占本公司总股本比例1.00%），以大宗交易方式减持公司股份不超过 6,959,543股（占本公司总股本比例2.00%）。截至本公告披露日，屠善增先生上述 减持计划尚未实施完毕。 证券代码：300702 证券简称：天宇股份 公告编号：2025-070 浙江天宇药业股份有限公司 关于控股股东、实际控制人之一致行动人减持股份触及 1%整数 倍的公告 股东屠善增保证向本公司提供的信息内容真实、准确、完整， 没有虚假记 载、误导性陈述或重大遗漏。 本公司董事会及全体董事保证本公告内容不存在虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 截至 2025 年 9 月 24 日，屠善增先生权益变动导致公司控股股东、实际控制 人及其一致行动人比例触及 5%整数倍，具体内容 ...

Group 1 - The company Tianyu Co., Ltd. held its fifth board meeting on September 30, 2025, with all seven directors present, chaired by Chairman Tu Yongjun [1] - The board approved a proposal to extend the timeline for a fundraising investment project, specifically the "Annual Production of 1,000 Tons of Sartan Main Ring and 19 Other Pharmaceutical Intermediate Industrialization Project," from November 30, 2025, to December 31, 2027, with unanimous approval [1] - The announcement included documents for reference, including the signed resolutions from the board meeting [1]

Group 1 - Tianyu Co., Ltd. (SZ 300702) held its 15th meeting of the 5th board of directors on September 29, 2025, to discuss the proposal for the extension of certain fundraising investment projects [1] - For the first half of 2025, Tianyu's revenue composition was as follows: 72.18% from generic drug raw materials and intermediates, 16.02% from CDMO raw materials and intermediates, 11.43% from formulations, and 0.37% from others [1] - As of the report date, Tianyu's market capitalization was 8.9 billion yuan [1] Group 2 - The competition between Farmer and Yibao has intensified, with Farmer's green bottle launch leading to a nearly 5 percentage point drop in Yibao's market share [1]

中信建投证券股份有限公司 关于浙江天宇药业股份有限公司 部分募集资金投资项目延期的核查意见 中信建投证券股份有限公司（以下简称"中信建投"或"保荐机构"）作为 浙江天宇药业股份有限公司（以下简称"天宇股份"或"公司"）持续督导的保 荐机构，根据《证券发行上市保荐业务管理办法》《上市公司募集资金监管规则》 《深圳证券交易所创业板股票上市规则》《深圳证券交易所上市公司自律监管指 引第 2 号——创业板上市公司规范运作》等法律法规的相关规定，对天宇股份部 分募集资金投资项目延期的事项进行了审慎核查，核查的具体情况如下： 一、天宇股份募集资金基本情况 经中国证券监督管理委员会证监许可〔2020〕2842 号文核准，并经深圳证 券交易所同意，本公司由主承销商中信建投采用代销方式，向特定对象发行人民 币普通股（A 股）股票 11,117,974 股，发行价为每股人民币 80.95 元，共计募集 资金 899,999,995.30 元，坐扣承销和保荐费用 4,245,283.02 元后的募集资金为 895,754,712.28 元，已由主承销商中信建投于 2020 年 12 月 29 日汇入本公司募集 资金监管账户。另减除 ...